Erratum: Nitric oxide levels in chronic liver disease patients with and without oesophageal varices (Hepatology International 10.1007/s12072-008-9077-y);Nitric oxide levels in chronic liver disease patients with and without oesophageal varices

Hepatology International

Volumn 2, Issue 3, 2008, Pages 341-345

  El Sherif, Assem M ^a   Abou Shady, Mohamed A ^a   Al Bahrawy, Ashraf M ^a   Bakr, Reda M ^a   Hosny, Abdel Moneim M ^a  

^a AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Chronic liver disease; Nitric oxide; Oesophageal varices

Indexed keywords

ALBUMIN; BILIRUBIN; HEMOGLOBIN; NITRATE; NITRIC OXIDE;

ADULT; ALBUMIN BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CHRONIC ACTIVE HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; ESOPHAGUS VARICES; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HUMAN; JAUNDICE; LEG EDEMA; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MALE; NITRATE BLOOD LEVEL; NITRIC OXIDE BLOOD LEVEL; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; PULSE RATE; SENSITIVITY AND SPECIFICITY; SPLENOMEGALY; THROMBOCYTE COUNT;

EID: 51049097668     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-008-9089-7     Document Type: Erratum

References (29)

1. Liu H, Gaskari SA, Lee SS. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol. 2006;12:837-42.
2. Langer DA, Shah VH. Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis. J Hepatol. 2006;44:209-16.
3. Moriyama A, Masumoto A, Nanri H, Tabaru A, Unoki H, Imoto I, Ikeda M, Otsuki M. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. Am J Gastroenterol. 1997;92:1520-3.
4. Arkenau HT, Stichtenoth DO, Frolich JC, Manns MP, Boker KH. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol. 2002;40:907-13.
5. Hassan MI, Kassim SK, Ali HS, Sayed el-DA, Khalifa A. Evaluation of nitric oxide (NO) levels in hepatitis C virus (HCV) infection: relationship to schistosomiasis and liver cirrhosis among Egyptian patients. Dis Markers. 2002;18:137-42.
6. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet. 1991;337:776-8.
7. Sogni P, Moreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J Hepatol. 1995;23:218-24.
8. Elsing C, Harenberg S, Stremmel W, Herrmann T. Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients. World J Gastroenterol. 2007;13:421-5.
9. Kirkali G, Gezer S, Umur N, Ozcan MA, Tankurt E. Nitric Oxide in chronic liver disease. Turk J Med Sci. 2000;30:511-5.
10. Pâryu AE, Negrean V, Pleca-Manea L, Cosma A, Drãghici A, Uifãlean A, Moldovan R. Nitric Oxide in patients with chronic liver diseases. Rom J Gastroenterol. 2005;14:225-30.
11. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. NEJM. 1998;339:533-41.
12. Schweyer S, Mihm S, Radzun HJ, Hartmann H, Fayyazi A. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut. 2000;46:255-9.
13. Kandemir O, Polat A, Kaya A. Inducible nitric oxide synthase expression in chronic viral hepatitis and its relation with histological severity of disease. J Viral Hepat. 2002;9:419-23.
14. Moussa YI, Plevris JN, Hyes PC. Plasma nitrites/nitrate in HCV infection and hepatocellular carcinoma. Eur J Gastroentrol Hepatol. 2000;12:159-63.
15. de Lucas S, Bartolome J, Amaro MJ, Carreno V. Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappa B activation. Antiviral Res. 2003;60:117-24.
16. Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology. 2004;126:886-94.
17. Morales-Ruiz M, Jimenez W. Neovascularization, angiogenesis, vascular remodeling in portal hypertension. In: Sanyal AJ, Shah VH, editors. Portal hypertension: Pathobiology, evaluation and treatment. Totowa NJ: humana press; 2005. p. 99-112.
18. Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularization: NO for endothelial progenitor. Trends Mol Med. 2004;10:143-5.
19. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol. 2000;32(1 Suppl):141-6.
20. Wattanasirichaigoon S, Gordon FD, Resnick RH. Hyperdynamic circulation in portal hypertension: A comparative model of arterio-venous fistula. Med Hypotheses. 2000;55:77-87.
21. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: A pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002;87:9-15.
22. Barak N, Zemel R, Ben-Ari Z, Braun M, Tur-Kaspa R. Nitric oxide metabolites in decompensated liver cirrhosis. Dig Dis Sci. 1999;44:1338-41.
23. de Franchis R, Dell'Era A, Iannuzzi F. Diagnosis and treatment of portal hypertension. Dig Liver Dis. 2004;36:787-98.
24. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of oesophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol. 1999;94:3292-6.
25. Ng FH, Wong SY, Loo CK, Lam KM, Lai CW, Cheng CS. Prediction of oesophagogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol. 1999;14:785-90.
26. Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, Madichetty H, Kwo PY, Boyer TD. Predictors of large oesophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999;94:3285-91.
27. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, Mele MR, Testa E, Mansi C, Savarino V, Testa R. Platelet count/spleen diameter ratio: Proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52:1200-5.
28. Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C, Savarino V, Testa R. Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: A validation study based on follow-up. Dig Liver Dis. 2005;37:779-85.
29. Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D, Krstic S, Krstic M. Right liver lobe/albumin ratio: Contribution to non-invasive assessment of portal hypertension. World J Gastroenterol. 2007;13:5331-5.